tiprankstipranks
Trending News
More News >

InhaleRx Limited Reports Quarterly Cash Flow with Focus on Sustaining Operations

Story Highlights
InhaleRx Limited Reports Quarterly Cash Flow with Focus on Sustaining Operations

Confident Investing Starts Here:

InhaleRx Limited ( (AU:IRX) ) has shared an announcement.

InhaleRx Limited’s recent quarterly cash flow report reveals a net cash outflow from operating activities amounting to $131,000, primarily due to expenditures on research and development, staff costs, and administration. Despite these outflows, the company maintained a stable cash position with no significant cash movements in investing or financing activities, indicating a focus on sustaining operations while managing expenses.

More about InhaleRx Limited

InhaleRx Limited operates in the healthcare industry, focusing on the development and commercialization of inhalation-based therapies. The company primarily engages in research and development, product manufacturing, and marketing of its healthcare solutions.

YTD Price Performance: -28.57%

Average Trading Volume: 175,783

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$5.34M

See more insights into IRX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App